| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.4 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.044 | 0.4 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |